BioMérieux, Biocartis Ink MDx Co-development Pact

BioMérieux also has made a €9 million ($12.8 million) equity investment in Biocartis as part of the deal.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories